Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety
Alessandro Vitale, Michael L. Volk, Davide Pastorelli, Sara Lonardi, Fabio Farinati, Patrizia Burra, Paolo Angeli, Umberto CilloVolume:
51
Year:
2010
Language:
english
Pages:
9
DOI:
10.1002/hep.23260
File:
PDF, 361 KB
english, 2010